AN ARIETTA.AI EXECUTIVE BRIEFING
Everything You’ve Been Told About AI In Pharmacovigilance Is Wrong
2024 Executive Briefing
The potential impact of Large Language Model (LLM)-based Artificial Intelligence (AI) solutions in pharmacovigilance is currently misunderstood. This executive brief aims to debunk five misconceptions, often espoused by legacy safety system vendors, and provide factual insights into the implementation and benefits of LLM-based AI solutions in pharmacovigilance.
Request your copy today